Caplin Point Laboratories announced that the US Food and Drug Administration (USFDA) conducted an unannounced inspection of its subsidiary Caplin Steriles’ injectable and ophthalmic manufacturing facility in Gummidipoondi, Tamil Nadu.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.